These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 5161753
1. [Behavior of lipoproteins in hepatic steatosis]. Ugazio G. Quad Sclavo Diagn; 1971 Dec; 7(4):994-1003. PubMed ID: 5161753 [No Abstract] [Full Text] [Related]
2. Considerations on the pathogenesis of fatty liver. Lombardi B. Lab Invest; 1966 Jan; 15(1 Pt 1):1-20. PubMed ID: 5931981 [No Abstract] [Full Text] [Related]
7. [Inhibitors of protein synthesis and hepatic steatosis: difference between cycloheximide, emetine and N-dimethylnitrosamine]. Gravela E, Bertone G, Poli G. Boll Soc Ital Biol Sper; 1974 Oct 30; 50(20):1674-9. PubMed ID: 4464015 [No Abstract] [Full Text] [Related]
11. [Possible relationship between hepatic steatosis caused by alpha-amanitine and lipoprotein metabolism in the rat]. Truhaut R, Thevenin M, Warnet JM, Claude JR. Ann Biol Clin (Paris); 1973 Oct 30; 31(2):111-3. PubMed ID: 4356106 [No Abstract] [Full Text] [Related]
13. [Effect of Trichodesma incanum seeds on the development of fatty dystrophy of the liver]. Abdullaev NKh, Azimov RK. Biull Eksp Biol Med; 1972 Aug 30; 73(8):28-9. PubMed ID: 4635279 [No Abstract] [Full Text] [Related]
16. Studies on myoinositol. VI. Effect of myoinositol on plasma lipoprotein metabolism of rats suffering from fatty liver. Hasan SH, Kotaki A, Yagi K. J Vitaminol (Kyoto); 1970 Jun 10; 16(2):144-8. PubMed ID: 5432877 [No Abstract] [Full Text] [Related]